Skip to main content Skip to main navigation menu Skip to site footer

The finding of subcutaneous emphysema on chest X-rays of COVID-19 patients at Prof. Dr. I.G.N.G Ngoerah General Hospital

Abstract

Introduction: Spontaneous subcutaneous emphysema without any invasive medical procedure was a rare and severe complication related to COVID-19 infection. Extensive alveolar damage caused by COVID-19 infection and sudden increase in intrathoracic pressure by cough mechanism were some of the risk factors underlying this event. Unlike the physical examination that could be performed only with limitation, mobile chest X-RAY as one of the imaging modalities was useful and plays an important role in supporting the diagnosis of COVID-19 infection and lung-related complications such as pneumothorax, pneumomediastinum, and subcutaneous emphysema.. Thus, the purpose of this study is to evaluate the findings of subcutaneous emphysema from chest X-rays in COVID-19 patients

Methods: The research design was descriptive quantitative which was conducted on May - Sep 2023 at the radiology Department of Prof. Dr. I.G.N.G Ngoerah General Hospital. The target population was all positive confirmed COVID-19 patients who had chest x-rays at Prof. Dr. I.G.N.G Ngoerah General Hospital. The data was collected from secondary sources from SIMARS and PACS and then tabulated and analyzed for gender, PCR results, age, vaccine status, and chest X-RAY findings for all samples. All of the data was analyzed with the SPSS.

Result: There were 40 cases collected for COVID-19. Most samples aged were more than 59 years old (42,5%). The mortality rate was 82,5%. with subcutaneous emphysema, 1,08% of all COVID-19 cases. 40% of which was followed by pneumomediastinum, 22,5% by pneumopericardium, and 15% by pneumothorax. The most subcutaneous emphysema region findings were at supraclavicular 88% and anterior cervical 83%. Iatrogenic subcutaneous emphysema is mostly caused by the usage of medical devices (82%).

Conclusion: Subcutaneous emphysema was a rare complication of severe COVID-19. Subcutaneous emphysema could be life-threatening if followed by pneumocytes, esophageal rupture, and infection or necrosis.

Section

References

  1. Zu ZY, Di Jiang M, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Vol. 296, Radiology. Radiological Society of North America Inc.; 2020. p. E15–25.
  2. Masyeni S, Nelwan EJ, Fatawy RM, Wibawa S, Nugraha PA, Antara J, et al. Clinical characteristics and outcomes of COVID-19 patients in Bali, Indonesia. PLoS One. 2022;17(6 June).
  3. Alsharif W, Qurashi A. Effectiveness of COVID-19 diagnosis and management tools: A review. Vol. 27, Radiography. W.B. Saunders Ltd; 2021. p. 682–7.
  4. Karacan A, Aksoy YE, Öztürk MH. The radiological findings of COVID-19. Turk J Med Sci. 2021;51:3327–39.
  5. Sathi S, Tiwari R, Verma S, Kumar Garg A, Singh Saini V, Kumar Singh M, et al. Role of Chest X-Ray in Coronavirus Disease and Correlation of Radiological Features with Clinical Outcomes in Indian Patients. Canadian Journal of Infectious Diseases and Medical Microbiology. 2021;2021.
  6. Toquica Gahona CC, Raj K, Bhandari K, Nuguru S, Bukhari A. Subcutaneous Emphysema in Patients With COVID-19 Infection: A Report of Three Cases. Cureus. 2020;
  7. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.
  8. Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, et al. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Vol. 111, Brain, Behavior, and Immunity. Academic Press Inc.; 2023. p. 211–29.
  9. Alsaffar WA, Alwesaibi AA, Alhaddad MJ, Alsenan ZK, Alsheef HJ, Alramadan SH, et al. The Effectiveness of COVID-19 Vaccines in Improving the Outcomes of Hospitalized COVID-19 Patients. Cureus. 2022;
  10. Hu Z, Felipe J, Arche V, Murillo-Zamora E. Waning immunity to SARS-CoV-2 following vaccination or infection.
  11. Johnson AG, Linde L, Ali AR, DeSantis A, Shi M, Adam C, et al. MMWR, COVID-19 Incidence and Death Rates Among Unvaccinated and Vaccinated Persons Ages ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 [Internet]. Vol. 1, Omicron BA. 2021. Available from: https://www.cdc.gov/nchs/data/statnt/statnt20.pdf
  12. Housman B, Jacobi A, Carollo A, Nobel T, Eber C, Acquah S, et al. COVID-19 ventilator barotrauma management: less is more. Ann Transl Med. 2020;8(23):1575–1575.
  13. Kukuruza K, Aboeed A. Subcutaneous Emphysema. 2023.
  14. Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20(1).
  15. Aghajanzadeh M, Alavi Foumani A, Tangestaninejad A, Haghighi M, Pourahmadi Y, Jafroudi EH, et al. Spontaneous tension pneumomediastinum with pneumothorax and subcutaneous emphysema as a complication of COVID‐19 disease. Clin Case Rep. 2023;11(7).
  16. Utomo SA, Notopuro F, Rosalina S. Massive emphysema subcutis, pneumothorax, pneumomediastinum and pneumoperitoneum as uncommon complication of covid-19 pneumonia, a rare case. Radiol Case Rep. 2021;16(8):2133–8.

How to Cite

Sitanggang, F. P., Sudiatmika, D. G. M. ., Anggreini, F. N. ., & Tampubolon, D. J. . (2023). The finding of subcutaneous emphysema on chest X-rays of COVID-19 patients at Prof. Dr. I.G.N.G Ngoerah General Hospital. Indonesia Journal of Biomedical Science, 17(2), 248–252. https://doi.org/10.15562/ijbs.v17i2.490

HTML
70

Total
101

Share

Search Panel

Firman Parulina Sitanggang
Google Scholar
Pubmed
IJBS Journal


Dewa Gde Mahiswara Sudiatmika
Google Scholar
Pubmed
IJBS Journal


Faradilla Novita Anggreini
Google Scholar
Pubmed
IJBS Journal


Darma Jupriadi Tampubolon
Google Scholar
Pubmed
IJBS Journal